| Breakdown | Mar 2026 | Mar 2025 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 233.43B | 343.18B | 465.74B | 503.84B | 452.80B |
| Gross Profit | 22.09B | 34.91B | 67.47B | 98.52B | 98.82B |
| EBITDA | -55.07B | -44.74B | 43.73B | 55.55B | 67.04B |
| Net Income | -88.56B | -49.48B | 12.16B | 37.55B | 38.07B |
Balance Sheet | |||||
| Total Assets | 1.02T | 1.29T | 1.50T | 1.76T | 1.94T |
| Cash, Cash Equivalents and Short-Term Investments | 67.31B | 88.34B | 99.83B | 137.23B | 149.37B |
| Total Debt | 209.21B | 235.87B | 278.34B | 339.71B | 294.00B |
| Total Liabilities | 784.76B | 947.41B | 1.10T | 1.35T | 1.55T |
| Stockholders Equity | 116.91B | 202.67B | 250.78B | 242.69B | 235.95B |
Cash Flow | |||||
| Free Cash Flow | -4.18B | -719.76M | -4.42B | -10.08B | -5.46B |
| Operating Cash Flow | -988.13M | 3.80B | 3.91B | 2.75B | 4.11B |
| Investing Cash Flow | 3.69B | 10.81B | -4.62B | -13.03B | -26.28B |
| Financing Cash Flow | -24.92B | -27.67B | -36.81B | 3.44B | -23.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$169.88B | 12.36 | 2.75% | 4.33% | 27.01% | -20.16% | |
67 Neutral | HK$118.29B | 15.34 | 2.20% | 5.62% | 30.32% | -1.37% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | HK$56.57B | 52.44 | 0.65% | 3.96% | -23.93% | -89.99% | |
54 Neutral | HK$135.50B | 7.48 | 3.54% | 4.54% | -9.39% | -19.08% | |
44 Neutral | HK$48.18B | -0.40 | -52.03% | ― | -31.93% | -79.74% | |
39 Underperform | HK$12.23B | 3.16 | -3.01% | ― | -38.67% | ― |